EMRELIS

Formula & Concentration

EMRELIS – telisotuzumab vedotin-tllv 100 mg intravenous solution

Manufacturer

AbbVie Inc.

Indications

EMRELIS – telisotuzumab vedotin-tllv 100 mg intravenous solution

Product Options

Package Size

NDC #

Presentation

100 MG

00074-1055-01

VIAL


20 MG

00074-1044-01

VIAL

Shelf Life and Storage

Fridge (2-8°C)